Flu Vaccine Supply (Flucelvax Trivalent)

The contract entails the supply of 2,000 units of FDA-approved Flucelvax Trivalent vaccine in 0.5 ml pre-filled single-dose syringes without needles, specifically for vaccination of the National Geospatial-Intelligence Agency workforce. The vaccine is intended for seasonal influenza prevention and must meet all regulatory standards for safety and efficacy as defined by the FDA. Delivery is required to be performed at the designated place of performance in Springfield, with all units shipped in compliant, ready-to-administer packaging. The contract is classified as a subcontract under NAICS code 325412, which corresponds to pharmaceutical preparation manufacturing. The solicitation was posted on July 31, 2026, and responses are due by August 10, 2026, at 10:00 PM Eastern Time. The contracting entity is the Department of Defense through the National Geospatial-Intelligence Agency, and no set-aside provisions are indicated, meaning the opportunity is open to all qualified vendors regardless of business size or ownership status.